Spliceosome protein Eftud2 promotes colitis-associated tumorigenesis by modulating inflammatory response of macrophage-Reference-Cited by-同舟云学术

Spliceosome protein Eftud2 promotes colitis-associated tumorigenesis by modulating inflammatory response of macrophage

Published:2019-07-05 Issue:5 Volume:12 Page:1164-1173
ISSN:1933-0219
Container-title:Mucosal Immunology
language:en
Short-container-title:Mucosal Immunol

Author:

Lv Zhonglin,Wang Zhihong,Luo Longlong,Chen Yu,Han Gencheng,Wang Renxi,Xiao He,Li Xinying,Hou Chunmei,Feng Jiannan,Shen Beifen,Wang Yi,Peng Hui,Guo Renfeng,Li Yan,Chen Guojiang

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/s41385-019-0184-y.pdf

Reference49 articles.

1. Eaden, J. A., Abrams, K. R. & Mayberry, J. F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48, 526–535 (2001).

2. Fiocchi, C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115, 182–205 (1998).

3. Fantini, M. C. & Pallone, F. Cytokines: from gut inflammation to colorectal cancer. Curr. Drug Targets 9, 375–380 (2008).

4. Ostuni, R., Kratochvill, F., Murray, P. J. & Natoli, G. Macrophages and cancer: from mechanisms to therapeutic implications. Trends Immunol. 36, 229–239 (2015).

5. Grivennikov, S. et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15, 103–113 (2009).

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural products with anti-tumorigenesis potential targeting macrophage;Phytomedicine;2024-08

2. Spliceosomal GTPase Eftud2 deficiency-triggered ferroptosis leads to Purkinje cell degeneration;Neuron;2024-08

3. Identification of the M2 Macrophage-associated Gene THBS2 as a Predictive Marker for Inflammatory Cancer Transformation;Inflammatory Bowel Diseases;2024-07-23

4. The Role of Natural Products from Herbal Medicine in TLR4 Signaling for Colorectal Cancer Treatment;Molecules;2024-06-07

5. Identification of HDAC9 and ARRDC4 as potential biomarkers and targets for treatment of type 2 diabetes;Scientific Reports;2024-03-25